Cargando…
Significance of clinical factors as prognostic indicators for patients with peripheral T-cell non-Hodgkin lymphoma: A retrospective analysis of 252 cases
The aim of this study was to retrospectively analyze the significance of different clinical factors for predicting the prognosis of patients with peripheral T-cell non-Hodgkin lymphoma (PTCL) with a median follow-up of 23 months. A total of 252 PTCL patients admitted to the First Affiliated Hospital...
Autores principales: | XIE, WANZHUO, HU, KEYUE, XU, FAN, ZHOU, DE, HUANG, WEIJIA, HE, JINGSONG, SHI, JIMIN, LUO, YI, ZHANG, JIE, LIN, MAOFANG, YE, XIUJIN, CAI, ZHEN, HUANG, HE |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3915658/ https://www.ncbi.nlm.nih.gov/pubmed/24649270 http://dx.doi.org/10.3892/mco.2013.146 |
Ejemplares similares
-
Clinical analysis and prognostic significance of lymphoma-associated hemophagocytosis in peripheral T cell lymphoma
por: Xie, Wanzhuo, et al.
Publicado: (2012) -
Clinical analysis and prognostic significance of hepatitis B virus infections for diffuse large B-cell lymphoma with or without rituximab therapy
por: XIE, WANZHUO, et al.
Publicado: (2013) -
An aggressive form of non-Hodgkin's lymphoma with pleural and abdominal chylous effusions: A case report and review of the literature
por: JIANG, YAJIAN, et al.
Publicado: (2013) -
Tumor Flare Reaction in a Classic Hodgkin Lymphoma Patient Treated With Brentuximab Vedotin and Tislelizumab: A Case Report
por: Zhu, Chunting, et al.
Publicado: (2022) -
Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin's Lymphoma and Role of β2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China
por: Zhang, Yujie, et al.
Publicado: (2022)